These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
225 related items for PubMed ID: 11253601
1. Stage II (T3) lung cancer. Allen MS, Jett JR, Kozelsky TF. Chest Surg Clin N Am; 2001 Feb; 11(1):61-7. PubMed ID: 11253601 [Abstract] [Full Text] [Related]
2. Stage II (N1) lung cancer. Choy O, Jahan T, Roach M, You L, Jablons D. Chest Surg Clin N Am; 2001 Feb; 11(1):39-59, viii. PubMed ID: 11253600 [Abstract] [Full Text] [Related]
5. The management of non-small-cell lung cancer with oligometastases. Downey RJ, Ng KK. Chest Surg Clin N Am; 2001 Feb; 11(1):121-32, ix. PubMed ID: 11253594 [Abstract] [Full Text] [Related]
16. Multimodality therapy for stage III non-small-cell lung cancer. Farray D, Mirkovic N, Albain KS. J Clin Oncol; 2005 May 10; 23(14):3257-69. PubMed ID: 15886313 [Abstract] [Full Text] [Related]
17. Non-small-cell lung cancer: multimodality approach in stage-III resectable disease. Thomas M, Hoffknecht P, Droege C, Baisch A, Reinmuth N, Kreuter M, Lange T, Berdel WE. Lung Cancer; 2004 Aug 10; 45 Suppl 2():S99-105. PubMed ID: 15552789 [Abstract] [Full Text] [Related]
19. [Locally advanced and metastatic non-small-cell lung cancer: towards a new optimal therapeutic strategy]. Fournel P. Rev Pneumol Clin; 2004 Jun 10; 60 Spec no 2():2S8-15. PubMed ID: 15211226 [No Abstract] [Full Text] [Related]
20. Assessing the value of neoadjuvant chemoradiotherapy and pathologic downstaging in the treatment of non-small cell lung cancer. D'Angelillo RM, Trodella L, Ramella S. J Thorac Cardiovasc Surg; 2004 Sep 10; 128(3):489-90. PubMed ID: 15354115 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]